Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Galzin ® (zinc acetate capsules) is now available for maintenance treatment of ...
Eton Pharmaceuticals has launched Galzin® (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease patients who have previously been treated with a chelating agent. To enhance ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Monopar Therapeutics' lead asset, ALXN1840, shows superior copper mobilization in Wilson Disease compared to standard care, with positive phase 3 trial results. The market for Wilson Disease ...
Monopar Therapeutics Inc. presented new data on its drug candidate ALXN1840 (tiomolybdate choline) for Wilson disease at the European Association for the Study of the Liver International Liver ...
On Monday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced preclinical findings highlighting the copper-binding potential of its lead compound, Telomir-1, as a promising treatment for Wilson's ...
Richard Rosencrantz, M.D.; Michael Schilsky, M.D. On physical exam, patients early on may have hepatomegaly, and over time may be seen to develop signs of chronic liver injury and cirrhosis with ...
In another example of the effect of modifier genes, Schiefermeier et al [45] tried to delineate why some patients have later-onset neurologic as well as hepatic symptoms by examining the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results